This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The principle used in the analysis of the effectiveness results (intention to treat or treatment completers only) was not specified. The outcomes used in the effectiveness analysis were: the percentage of physicians performing initial flexible sigmoidoscopy or colonoscopy; use of sedation (>75% of the time); the percentage of physicians (from those performing initial flexible sigmoidoscopy) who would perform colonoscopy if diffuse colitis extends proximal to rectosigmoid, the percentage who would perform colonoscopy if evidence of Crohn's disease were found on flexible sigmoidoscopy, the percentage who would complete colonoscopy if diffuse colitis extends proximal to rectosigmoid, the percentage who would complete colonoscopy if Crohn's disease were in rectosigmoid area;the percentage of physicians (from physicians performing colonoscopy) who would complete colonoscopy if diffuse colitis extends proximal to rectosigmoid, and the percentage who would complete colonoscopy if Crohn's disease were in rectosigmoid area.
Effectiveness results
The percentage of physicians performing initial flexible sigmoidoscopy was 36% against 64% for colonoscopy.
The use of sedation more than 75% of the time was 78%.
The percentage of physicians (from physicians performing initial flexible sigmoidoscopy) who would perform colonoscopy if diffuse colitis extends proximal to rectosigmoid was 56%.
The percentage who would perform colonoscopy if evidence of Crohn's disease found on flexible sigmoidoscopy was 52%.
The percentage who would complete colonoscopy if diffuse colitis extends proximal to rectosigmoid was 50%.
The percentage who would complete colonoscopy if Crohn's disease in rectosigmoid area was 58%.
The percentage of physicians (from those performing colonoscopy) who would complete colonoscopy if diffuse colitis extends proximal to rectosigmoid was 82%.
The percentage who would complete colonoscopy if Crohn's disease in rectosigmoid area was 96%.
Clinical conclusions
Recognition, prior to the procedure, that knowledge of the extent of disease is important to the physician, should lead to the more cost-effective choice of initial colonoscopy.
Modelling
A decision analysis program (Data 2.5. Tree Age, Boston, MA, USA) was used to estimate the cost-effectiveness of thetwo strategies. A decision tree was used.
Outcomes assessed in the review
The outcomes assessed in the review were: incidence of Crohn's disease versus ulcerative colitis for pediatric patients, incidence of patients with indeterminate colitis, incidence of patients with colonic involvement in Crohn's disease, incidence of Crohn's patients with rectosigmoid involvement, relative incidence of the extent of disease in ulcerative colitis for patients with pancolitis versus for patients with limited rectosigmoid disease.
Sources searched to identify primary studies

Not stated
Criteria used to ensure the validity of primary studies Not stated.
Methods used to judge relevance and validity, and for extracting data
Not stated.
Number of primary studies included
At least 14 studies were included in the review.
Methods of combining primary studies
Investigation of differences between primary studies
Results of the review
Based on the survey results and a review of the literature the outcome values estimated were:
incidence of Crohn's disease versus ulcerative colitis for pediatric patients was0.6, and 0.4; incidence of patients with indeterminate colitis was 0.10; incidence of patients with colonic involvement in Crohn's disease was 0.60; incidence of Crohn's patients with rectosigmoid involvement was 0.70; relative incidence of the extent of disease in ulcerative colitis was 0.62 for patients with pancolitis versus 0.37 for patients with limited rectosigmoid disease.
Measure of benefits used in the economic analysis
The percentage of physicians, who would proceed following each scenario, was calculated in the decision model.
Direct costs
Quantities and costs were not reported separately. All charges due to the interventions consisting of professional, room, medication and recovery room, and pathology charges were included. The cost items were not reported separately. The main cost measure was the median charge ratio (total charges for flexible sigmoidoscopy/total charges for colonoscopy)as a proxy for true cost ratio. The quantity/cost boundary was not stated. The price date was not stated. The costs associated with side-effects of the two health technologies were not included since they were assumed to be common to the alternatives.
